Cabaletta Bio, Inc. (CABA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CABA currently has 163M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 155.51% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 163.1M shares outstanding |
160M | 0 |
| Mar 23, 2026 |
10-K filing | 111.3M shares outstanding |
110M | 50M |
| Nov 10, 2025 |
10-Q filing | 96.3M shares outstanding |
96M | 65M |
| Aug 07, 2025 |
S-3 filing: The filing relates to a shelf offering of common stock, preferred stock, debt securities, warrants and/or units with an aggregate principal amount of up to $240,000,000. The company intends to use the net proceeds from the offering to fund research and clinical development of current or additional pipeline candidates, working capital, capital expenditures, and general corporate purposes. |
91M | 70M |
| Aug 07, 2025 |
10-Q filing | 91.5M shares outstanding |
91M | 0 |
| May 15, 2025 |
10-Q filing | 49.3M shares outstanding |
49M | 12M |
| Mar 31, 2025 |
POS AM filing: The filing is a POS AM (Post-Effective Amendment) related to a shelf offering of up to $400,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants and/or units, with common stock being offered at the market through TD Securities (USA) LLC. |
51M | 10M |
| Mar 31, 2025 |
10-K filing | 49.5M shares outstanding |
50M | 12M |
| Nov 14, 2024 |
10-Q filing | 49.5M shares outstanding |
49M | 12M |
| Aug 08, 2024 |
10-Q filing | 49.4M shares outstanding |
49M | 12M |
| May 15, 2024 |
10-Q filing | 49.3M shares outstanding |
49M | 12M |
| Mar 21, 2024 |
10-K filing | 48.2M shares outstanding |
48M | 13M |
| Nov 09, 2023 |
10-Q filing | 44.0M shares outstanding |
44M | 17M |
| Aug 10, 2023 |
10-Q filing | 39.2M shares outstanding |
39M | 22M |
| May 11, 2023 |
10-Q filing | 31.4M shares outstanding |
31M | 30M |
| Mar 16, 2023 |
10-K filing | 29.3M shares outstanding |
29M | 32M |
| Mar 16, 2023 |
S-3 filing: The filing is for a potential offering of up to $350,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants and/or units, and also covers an at-the-market offering of common stock with an aggregate offering price of up to $100,000,000. |
29M | 32M |
| Nov 10, 2022 |
10-Q filing | 29.0M shares outstanding |
29M | 18M |
| Aug 11, 2022 |
10-Q filing | 29.0M shares outstanding |
29M | 18M |
| May 12, 2022 |
10-Q filing | 29.0M shares outstanding |
29M | 19M |
| Mar 17, 2022 |
10-K filing | 29.0M shares outstanding |
29M | 18M |
| Nov 01, 2021 |
10-Q filing | 25.8M shares outstanding |
26M | 22M |
| Aug 05, 2021 |
10-Q filing | 24.7M shares outstanding |
25M | 23M |
| May 03, 2021 |
10-Q filing | 23.8M shares outstanding |
24M | 24M |
| Mar 16, 2021 |
10-K filing | 23.1M shares outstanding |
23M | 24M |
| Nov 10, 2020 |
S-3 filing: The company may issue up to $250,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants and/or units from time to time. It also has an active atm offering for common stock up to $75,000,000. |
24M | 23M |
| Nov 10, 2020 |
10-Q filing | 23.3M shares outstanding |
23M | 24M |
| Aug 06, 2020 |
10-Q filing | 23.0M shares outstanding |
23M | 0 |
| May 12, 2020 |
10-Q filing | 22.8M shares outstanding |
23M | 0 |
| Mar 30, 2020 |
10-K filing | 24.0M shares outstanding |
24M | 0 |